Alcimed’s teams have been exploring innovations in digital information sharing infrastructures for more than 10 years, and in particular the potential and opportunities related to Blockchain technology. Alcimed supports its clients in understanding the blockchain market, its applications and its potential for value creation.
Challenges related to Blockchain or Distributed Ledger technology
What is blockchain and what is a distributed ledger?
The genesis of the blockchain goes back to 2007, when Satoshi Nakamoto – a pseudonym used by the person(s) who developed the bitcoin – worked on a decentralized, peer-to-peer electronic money experiment. This was based on the work of Stornetta and Haber of 1991, called “how to time stamp a document”, and consisted in meeting the imperatives of time-stamping, inviolability and suppression of the concept of trusted third party.
Today, in its modern definition, a blockchain is a distributed ledger (or database) – hence the term distributed ledger – which makes it possible to efficiently record and trace any type of data transaction, in a verifiable and permanent manner. All its users simultaneously share this register: they are all holders of it, and can enter data in it, according to specific rules set by a secure computer protocol using cryptography. A blockchain is therefore an information-sharing infrastructure, that guarantees transparency, security, monitoring and traceability.
What are the challenges related to blockchain?
Beyond the 1.5 trillion euros (or 1,500 billion) of the cryptocurrency market in June 2021, the private blockchain market, used by companies for services or products, could reach 40 billion in 2025.
Although the banking service holds the lion’s share with, in particular, the applications for securing financial transactions with players such as Visa or Moneygram, there are other sectors that can also benefit from blockchain technology: healthcare, mobility, administrations, energy, etc. In healthcare in particular, the potential of the blockchain can be applied to the traceability of drugs, the security of patient records, the recruitment and monitoring of patients in clinical trials, serialization, etc.
As this market is developing, manufacturers, pharmaceutical laboratories, biotechs and hospitals are facing numerous challenges, including:
Which blockchain technology to use? Should it be private or public? How to minimize the risks of security breaches?
How could interactions be facilitated between the different bodies of the system? Which technology should be chosen and why? How could standards be selected or created to ensure the best operational efficiency?
What can we expect from legislators regarding blockchain? What are the differences between countries and regions? What actions can we reasonably initiate today?
How do we support you in your blockchain technology projects?
Alcimed supports its clients in their blockchain-related projects and in particular in evaluating and exploiting the potential and opportunities of blockchain technology in a B2B environment. While this technology is already finding practical applications in finance and cryptocurrency (e.g. Bitcoin, Ethereum), we are exploring its specific applications in areas that have yet to be fully explored, such as healthcare or mobility.
The diversity of our clients (industrial companies, start-ups, national or European institutes, etc.), of the geographic areas we explore, and the types of projects we develop, give us a global and comprehensive insight into issues related to blockchain.
Our projects around blockchain cover areas as diverse as characterizing new technologies and their applications, building a case for financing a collaborative project, evaluating blockchain opportunities and associated new business models, defining use cases, finding partners and regulatory developments.
The types of projects we carry out for our clients in this field are:
EXAMPLES OF RECENT PROJECTS CARRIED OUT FOR OUR CLIENTS IN THE FIELD OF BLOCKCHAIN
Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.
Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.
Our dream? To build a team of 1,000 explorers, to design tomorrow's world hand in hand with our clients.
- Proof of concept
- Voice of Customer (VOC)
- Business case
- Business development
- Business models
- Business plan
- Cluster study
- Collaborative projects
- Commercial strategy
- Competitive analysis
- Customer experience
- Dossier creation
- Due diligence
- Go to market
- Innovation consulting
- Innovation process
- Innovation strategy
- Learning expedition
- Market access
- Market study
- New offers
- New services
- Open innovation
- Opportunity evaluation
- Patient pathway
- Product innovation
- Product launch
- Regulatory framework analysis
- Search for funding opportunities
- Search for partners
- State of the art
- Strategic audit
- Strategic foresight
- Strategic positioning
- Test and Learn
- Value proposition